AffiliationDepartment of Histopathology, The Christie NHS Foundation Trust, Manchester, UK
MetadataShow full item record
AbstractFoxA1 regulates a variety of tissues during embryogenesis and early life. In thyroid, FoxA1 expression has recently been shown in C cells and medullary thyroid carcinomas but not in follicular cells. FoxA1 has also been proposed as potential oncogene in anaplastic thyroid carcinomas. However, FoxA1 expression has not been extensively investigated in a spectrum of thyroid non-neoplastic lesions and tumors. A variety of thyroid tumors and lesions and their morphologic mimics were stained with monoclonal anti-FoxA1 antibody. For the medullary carcinomas, its expression pattern was compared with those of other conventional markers. All 67 medullary thyroid carcinomas (100%), including one calcitonin-negative medullary carcinoma, showed diffuse and strong FoxA1 nuclear expression. The expression pattern was homogeneous throughout the tumor. Expressions of other markers in medullary thyroid carcinomas were as follows: calcitonin 94.7%, CEA 91.2%, and chromogranin 100%, generally in variable intensity. FoxA1 was completely negative in follicular neoplasms, papillary thyroid carcinomas and poorly differentiated carcinomas while it was expressed in 55% of anaplastic thyroid carcinomas (33/60) in variable intensity. FoxA1 was also strongly expressed in C cell hyperplasia as well as solid cell nests. No FoxA1 expression was seen in thyroid gland affected by nodular hyperplasia, Hashimoto thyroiditis, and Graves disease, or in paragangliomas or parathyorid lesions. FoxA1 discriminates between medullary thyroid carcinoma and tumors of follicular derivation with sensitivity and specificity greater than calcitonin and CEA, therefore, it may serve as a reliable ancillary marker for the diagnosis of medullary thyroid carcinoma, due to its reliably uniform quality of staining.
CitationA study of FoxA1 expression in thyroid tumors. 2017 Hum Pathol
- Signification of forkhead box A1 (FOXA1) expression in thyroid cancers.
- Authors: Missaoui N, Chouaibi S, Limam S, Mhamdi N, Zahmoul T, Hamchi H, Mokni M, Hmissa S
- Issue date: 2019 Dec 30
- Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions.
- Authors: Komminoth P, Roth J, Saremaslani P, Matias-Guiu X, Wolfe HJ, Heitz PU
- Issue date: 1994 Apr
- Epithelial markers in thyroid carcinoma: an immunoperoxidase study.
- Authors: Wilson NW, Pambakian H, Richardson TC, Stokoe MR, Makin CA, Heyderman E
- Issue date: 1986 Aug
- Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
- Authors: Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R
- Issue date: 2008 Feb
- Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid.
- Authors: Hirsch MS, Faquin WC, Krane JF
- Issue date: 2004 Jun